首页> 美国卫生研究院文献>Oncology Letters >Effects of knockout of lincRNA-p21 on the proliferation migration and invasion ability of HepG2 liver cancer cells
【2h】

Effects of knockout of lincRNA-p21 on the proliferation migration and invasion ability of HepG2 liver cancer cells

机译:LincRNA-p21基因敲除对HepG2肝癌细胞增殖迁移和侵袭能力的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Effects of long intergenic non-coding RNA (lincRNA)-p21 on the proliferation, migration and invasion ability of HepG2 liver cancer cells were assessed to explore the underlying mechanism. The lincRNA-p21 small interfering RNA (siRNA) lentivirus vector was constructed, transfected and screened to obtain a stable cell line, which constituted the experimental group. At the same time, the empty virus vector was transfected as the control group. The messenger RNA (mRNA) expression of lincRNA-p21 in cells was detected via reverse transcription-polymerase chain reaction (RT-PCR). The proliferation ability of cells was detected via Cell Counting kit-8 (CCK-8) assay. Transwell chamber experiment was used to observe cell migration and invasion ability. Compared with that in the control group, the mRNA expression level of lincRNA-p21 in cells in the experimental group was obviously decreased (p<0.05). Results of CCK-8 showed that the proliferation ability of liver cancer cells was remarkably higher than that in the control group after knockout of lincRNA-p21 (p<0.05). Results of the Transwell chamber experiment revealed that the invasion and migration ability of HepG2 cells in experimental group was markedly higher than that in control group (p<0.05). When lincRNA-p21 was inhibited, the proliferation, invasion and migration ability of HepG2 cells were significantly enhanced, and the apoptosis rate was significantly decreased. Thus, lincRNA-p21 on the surface may play an inhibitory role in the occurrence, development and metastasis of liver cancer.
机译:评估了长基因间非编码RNA(lincRNA)-p21对HepG2肝癌细胞增殖,迁移和侵袭能力的影响,以探索其潜在机制。构建,转染并筛选了lincRNA-p21小干扰RNA(siRNA)慢病毒载体,获得稳定的细胞系,构成实验组。同时,将空病毒载体转染为对照组。通过逆转录聚合酶链反应(RT-PCR)检测了lincRNA-p21的信使RNA(mRNA)表达。通过细胞计数试剂盒8(CCK-8)测定法检测细胞的增殖能力。用Transwell室实验观察细胞的迁移和侵袭能力。与对照组相比,实验组细胞中lncRNA-p21的mRNA表达水平明显降低(p <0.05)。 CCK-8结果显示,敲除lincRNA-p21后,肝癌细胞的增殖能力明显高于对照组(p <0.05)。 Transwell室实验结果表明,实验组HepG2细胞的侵袭和迁移能力明显高于对照组(p <0.05)。抑制lincRNA-p21后,HepG2细胞的增殖,侵袭和迁移能力显着增强,凋亡率明显降低。因此,表面上的lincRNA-p21可能在肝癌的发生,发展和转移中起抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号